NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ: CLDA), today announced that Drew Fromkin, President and Chief Executive Officer, and Dr. Carol Reed, Executive Vice President and Chief Medical Officer, will be presenting a corporate overview at the Ninth Annual BMO Capital Markets’ Focus on Healthcare Conference. The presentation will include updates on vilazodone, in development for major depressive disorder and Stedivaze™, a vasodilator in development for use in cardiac stress testing. Clinical Data's presentation will take place at 8:30 a.m. EDT. on Wednesday, August 5, 2009 at the Millennium Broadway Hotel, New York, NY.
